Cosmo Pharmaceuticals N.V. (LON:0RGI)

Cosmo Pharmaceuticals Statistics

Total Valuation

LON:0RGI has a market cap or net worth of GBP 995.17 million. The enterprise value is 891.47 million.

Market Cap	995.17M
Enterprise Value	891.47M

Important Dates

The last earnings date was Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	Jun 4, 2025

Share Statistics

Current Share Class	15.94M
Shares Outstanding	n/a
Shares Change (YoY)	+1.65%
Shares Change (QoQ)	-4.28%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	15.93%
Float	8.44M

Valuation Ratios

The trailing PE ratio is 19.35 and the forward PE ratio is 32.29.

PE Ratio	19.35
Forward PE	32.29
PS Ratio	6.37
PB Ratio	2.49
P/TBV Ratio	10.84
P/FCF Ratio	17.13
P/OCF Ratio	15.79
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.41, with an EV/FCF ratio of 15.35.

EV / Earnings	17.34
EV / Sales	5.53
EV / EBITDA	12.41
EV / EBIT	14.66
EV / FCF	15.35

Financial Position

The company has a current ratio of 3.84, with a Debt / Equity ratio of 0.01.

Current Ratio	3.84
Quick Ratio	3.59
Debt / Equity	0.01
Debt / EBITDA	0.03
Debt / FCF	0.04
Interest Coverage	763.58

Financial Efficiency

Return on equity (ROE) is 12.34% and return on invested capital (ROIC) is 8.80%.

Return on Equity (ROE)	12.34%
Return on Assets (ROA)	6.88%
Return on Invested Capital (ROIC)	8.80%
Return on Capital Employed (ROCE)	12.24%
Revenue Per Employee	470,607
Profits Per Employee	154,891
Employee Count	322
Asset Turnover	0.29
Inventory Turnover	3.64

Taxes

In the past 12 months, LON:0RGI has paid 10.43 million in taxes.

Income Tax	10.43M
Effective Tax Rate	16.87%

Stock Price Statistics

The stock price has increased by +0.59% in the last 52 weeks. The beta is 1.28, so LON:0RGI's price volatility has been higher than the market average.

Beta (5Y)	1.28
52-Week Price Change	+0.59%
50-Day Moving Average	66.41
200-Day Moving Average	59.68
Relative Strength Index (RSI)	38.97
Average Volume (20 Days)	3,185

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RGI had revenue of GBP 156.24 million and earned 51.42 million in profits. Earnings per share was 3.14.

Revenue	156.24M
Gross Profit	115.28M
Operating Income	58.91M
Pretax Income	61.85M
Net Income	51.42M
EBITDA	68.96M
EBIT	58.91M
Earnings Per Share (EPS)	3.14

Balance Sheet

The company has 108.54 million in cash and 2.31 million in debt, giving a net cash position of 106.23 million.

Cash & Cash Equivalents	108.54M
Total Debt	2.31M
Net Cash	106.23M
Net Cash Per Share	n/a
Equity (Book Value)	400.29M
Book Value Per Share	24.75
Working Capital	118.73M

Cash Flow

In the last 12 months, operating cash flow was 63.01 million and capital expenditures -4.93 million, giving a free cash flow of 58.08 million.

Operating Cash Flow	63.01M
Capital Expenditures	-4.93M
Free Cash Flow	58.08M
FCF Per Share	n/a

Margins

Gross margin is 73.79%, with operating and profit margins of 37.70% and 32.91%.

Gross Margin	73.79%
Operating Margin	37.70%
Pretax Margin	39.59%
Profit Margin	32.91%
EBITDA Margin	44.14%
EBIT Margin	37.70%
FCF Margin	37.17%

Dividends & Yields

This stock pays an annual dividend of 1.73, which amounts to a dividend yield of 2.57%.

Dividend Per Share	1.73
Dividend Yield	2.57%
Dividend Growth (YoY)	2.89%
Years of Dividend Growth	2
Payout Ratio	94.36%
Buyback Yield	-1.65%
Shareholder Yield	0.92%
Earnings Yield	5.17%
FCF Yield	5.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0RGI has an Altman Z-Score of 6.36 and a Piotroski F-Score of 4.

Altman Z-Score	6.36
Piotroski F-Score	4